森萱医药
(830946)
| 流通市值：31.53亿 | | | 总市值：31.55亿 |
| 流通股本：4.27亿 | | | 总股本：4.27亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 513,461,081.25 | 505,949,141.18 | 454,937,952.93 | 375,334,401.93 |
| 应收票据及应收账款 | 54,577,450.05 | 50,087,944.54 | 54,790,578.61 | 70,102,772.44 |
| 其中：应收票据 | 12,445,906.51 | 15,850,023.4 | 8,178,331.61 | 11,325,973.14 |
| 应收账款 | 42,131,543.54 | 34,237,921.14 | 46,612,247 | 58,776,799.3 |
| 应收款项融资 | 37,911,622.12 | 29,954,234.19 | 52,052,682.57 | 36,733,557.28 |
| 预付款项 | 5,637,160.66 | 6,992,289.11 | 8,744,147.29 | 9,386,737.34 |
| 其他应收款合计 | 217,305.92 | 210,301.63 | 797,170.76 | 1,162,947.86 |
| 存货 | 146,378,353.94 | 145,993,690.74 | 145,196,152.34 | 145,945,195.62 |
| 一年内到期的非流动资产 | 45,283,333.32 | 44,115,500 | - | 2,438,333.32 |
| 其他流动资产 | 2,977.67 | 99,006.31 | 222,175.09 | 879,136.33 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 940,739,010.96 | 919,659,863.87 | 833,014,928.08 | 783,135,451.98 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | 44,000,000 | 44,000,000 |
| 固定资产 | 341,639,869.66 | 352,114,874.54 | 362,407,014.76 | 373,734,391.71 |
| 在建工程 | 23,454,152.42 | 9,854,529.85 | 113,925.49 | - |
| 使用权资产 | 2,820,779.03 | 2,815,369.65 | 2,394,968 | 2,770,115.87 |
| 无形资产 | 36,519,049.9 | 36,821,513.26 | 37,123,976.6 | 37,426,439.95 |
| 递延所得税资产 | 5,403,383.1 | 5,032,549.92 | 9,530,396.76 | 9,142,014.8 |
| 其他非流动资产 | - | 1,014,595 | - | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 409,837,234.11 | 407,653,432.22 | 455,570,281.61 | 467,072,962.33 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,350,576,245.07 | 1,327,313,296.09 | 1,288,585,209.69 | 1,250,208,414.31 |
| 流动负债: | | | | |
| 短期借款 | 20,023,541.7 | 20,023,541.69 | 20,020,859.73 | 9,008,637.5 |
| 应付票据及应付账款 | 33,873,286.51 | 38,965,566.47 | 38,581,883.18 | 46,913,461.07 |
| 其中：应付票据 | 1,537,865.6 | 3,382,136.54 | 7,936,985.1 | 12,501,809.21 |
| 应付账款 | 32,335,420.91 | 35,583,429.93 | 30,644,898.08 | 34,411,651.86 |
| 合同负债 | 4,780,720.49 | 5,067,012.82 | 5,786,142.19 | 2,321,062.83 |
| 应付职工薪酬 | 15,335,865.17 | 23,536,847.71 | 19,156,693.75 | 16,420,344.23 |
| 应交税费 | 8,007,033.69 | 7,476,861.55 | 8,388,046.23 | 7,498,218.67 |
| 其他应付款合计 | 6,371,071.37 | 5,994,679.17 | 5,948,720.18 | 7,265,177.63 |
| 一年内到期的非流动负债 | 1,742,302.56 | 1,488,187.23 | 1,036,456.11 | 1,036,456.11 |
| 其他流动负债 | 5,441,586.46 | 6,957,055.42 | 1,312,473.11 | 104,894.55 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 95,575,407.95 | 109,509,752.06 | 100,231,274.48 | 90,568,252.59 |
| 非流动负债: | | | | |
| 租赁负债 | 947,696.71 | 1,014,879.98 | 1,121,285.08 | 1,144,601.8 |
| 递延收益 | 2,182,941.16 | 2,228,235.28 | 1,313,529.4 | 1,358,823.52 |
| 递延所得税负债 | 5,199,271.53 | 4,982,573.8 | 6,991,828.33 | 7,230,447.24 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 8,329,909.4 | 8,225,689.06 | 9,426,642.81 | 9,733,872.56 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 103,905,317.35 | 117,735,441.12 | 109,657,917.29 | 100,302,125.15 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 426,918,340 | 426,918,340 | 426,918,340 | 426,918,340 |
| 资本公积 | 217,559,039.68 | 217,559,039.68 | 217,559,039.68 | 217,559,039.68 |
| 专项储备 | 2,179,039.66 | 1,506,441.88 | 2,525,977.11 | 2,031,055.09 |
| 盈余公积 | 42,041,795.43 | 42,041,795.43 | 34,014,929.62 | 34,014,929.62 |
| 未分配利润 | 482,834,146.66 | 447,972,391.44 | 424,855,598.11 | 398,168,585.59 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,171,532,361.43 | 1,135,998,008.43 | 1,105,873,884.52 | 1,078,691,949.98 |
| 少数股东权益 | 75,138,566.29 | 73,579,846.54 | 73,053,407.88 | 71,214,339.18 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,246,670,927.72 | 1,209,577,854.97 | 1,178,927,292.4 | 1,149,906,289.16 |
| 负债和股东权益合计 | 1,350,576,245.07 | 1,327,313,296.09 | 1,288,585,209.69 | 1,250,208,414.31 |
| 公告日期 | 2024-04-29 | 2024-04-18 | 2023-10-27 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |